Location History:
- Gothenburg, SE (2005)
- Molndal, SE (2005 - 2007)
- Mölndal, SE (2008)
Company Filing History:
Years Active: 2005-2008
Title: Ingela Niklasson Björn: A Pioneer in Pharmaceutical Coating Technologies
Introduction: Ingela Niklasson Björn is a notable inventor based in Molndal, Sweden, recognized for her significant contributions to the field of pharmaceutical coatings. With a total of four patents to her name, she has developed innovative methods and devices that enhance the production and efficacy of pharmaceutical products. Her work continues to influence the industry positively.
Latest Patents: Ingela has recently patented groundbreaking technologies, including a method and device for coating pharmaceutical products. This invention details a sophisticated method for producing discrete droplets of controlled size, shape, and composition, which are utilized in the pharmaceutical coating process. The method specifically involves utilizing a micro dispenser for distributing droplets with precise control over velocity and flight time. Additionally, Ingela's invention encompasses aspects such as controlling production frequency and the attributes of the carrier gas to effectively direct droplets toward the particles needing coating.
Another notable patent pertains to a sampling apparatus designed for on-line material sampling within process systems. This innovative apparatus features a sample collector, an elongate shaft housing a measurement probe for collecting samples, and a pressurized fluid supply that ensures efficient sample displacement for accurate measurement and analysis.
Career Highlights: Ingela Niklasson Björn is employed by AstraZeneca AB, a global leader in the biopharmaceutical industry. Her tenure at AstraZeneca has allowed her to collaborate on various cutting-edge projects that focus on drug development and delivery, where her inventive solutions have proved invaluable.
Collaborations: Throughout her career, Ingela has collaborated with a talented team, including coworkers such as Staffan Folestad and Lennart Björk. These collaborations have further enriched her work, showcasing the importance of teamwork in the innovation process.
Conclusion: Ingela Niklasson Björn exemplifies the role of women in science and technology through her exceptional work and contributions to pharmaceutical innovations. Her patents not only advance the industry but also inspire future generations of inventors and researchers. With her ongoing commitment to improving pharmaceutical processes, Ingela stands as a significant figure in the realm of innovation.